ReviewFrontiers in bioengineering and biotechnology2026
Clinical biomarkers and biosensors for early detection of metabolic dysfunction-associated steatohepatitis (MASH): a translational perspective.
Fareeha Arshad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.